6th Annual Achieving Quality & Process Excellence in the Pharmaceutical Industry

Jacob Fleming Conferences15-17 September 2010, Lisbon, Portugal.
What are the best practices to achieve QC Laboratory Excellence? How successful are you in adopting and sustaining consistent, harmonized & compliant quality systems?

Leading Pharmaceutical companies will share their first hand experience with transforming the mindset of people, creating the culture of change and continuous improvement in both Quality and Operational Excellence.

Understand, what is the future of Quality organization and how is the role of QA & QC changing in 21st century. Learn how & where to deploy and develop measurable quality systems, Quality Risk Management, QbD & PAT.

Reveal, how to achieve and sustain better costs, productivity and speed through lean six sigma, kaizen and continuous improvement projects.

This event will bring together senior industry quality & operational excellence experts from the pharmaceutical industry presenting real life case studies as well as a lot of networking sessions and discussions.

Key speakers:

  • Head PharmOps QA, Novartis, Switzerland
  • Director/Senior Operational Excellence Leader EMEA, Pfizer, USA
  • Global Head Integrated Risk Management, Pharma Technical Operations - Supply Chain, Roche, Switzerland
  • Vice President Quality, Genzyme, Ireland
  • Head Quality Control Department, Teva, Hungary
  • Head Corporate Quality Assurance,UCB, Belgium
  • Vice President Biopharma Operations, Boehringer Ingelheim, Germany
  • Quality Assurance EMACM, (European, Middle Eastern & African Contract Mfg), Eli Lilly, Italy
  • Head GLP QA, MerckSerono, Italy

Key topics:

  • Case studies on deploying, sustaining & improving consistent, harmonized & compliant quality systems
  • Reveal the future of Quality Organization – interaction between lean & quality in the lab, and changing role of QA & QC in the 21st century
  • Achieving quicker adoption and less ambiguity surrounding ICH Q 8, Q 9 and Q 10 guidance
  • Explore current developments and future trends in Quality by Design & PAT
  • Critical insights on Quality Risk Management
  • Exploit the pathway to compliance based Operational Excellence & Process Improvements – Lean Six Sigma, Kaizen & Continuous Improvement Journey
  • Improving Quality at Contract Manufacturers – real life case studies

Who should attend:
Vice Presidents, Heads, Directors, Senior Managers and Managers of:
Quality Management, Quality Assurance, Quality Operations, Quality Control, Quality Systems, Contract Manufacturing, Operational Excellence, Supply Chain, GMP Compliance, Innovation, PAT, Lean/SixSigma, Lean Manufacturing, API manufacturing, Technical operations, Business Process Management

For further information and registration, please visit:
http://www.jacobfleming.com/jacob-fleming-group/conferences/life-science/6thPharmaQuality

About the Jacob Fleming Conferences
Jacob Fleming Conferences have always been carefully designed to provide key strategic business information and the best networking opportunities for the participants. This young, dynamically growing company provides events for specialized industries including Finance, Life Science, Telecommunications, Chemical, and cross industry sectors. Extensive research, targeted speaker selection and top class venues provide a unique incentive and exceptional opportunities for the executives and experts participating in Jacob Fleming conferences. For more information, visit www.jacobfleming.com.

Most Popular Now

Time-restricted eating reshapes gene expression th…

Numerous studies have shown health benefits of time-restricted eating including increase in life span in laboratory studies, making practices like intermittent fasting a ...

Incurable liver disease may prove curable

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the li...

Scientists develop a cancer vaccine to simultaneou…

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s ...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

COVID-19 vaccines, prior infection reduce transmis…

Vaccination and boosting, especially when recent, helped to limit the spread of COVID-19 in California prisons during the first Omicron wave, according to an analysis by ...

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...